Truist Securities Upgrades Globus Medical (GMED) to Buy
Tweet Send to a Friend
Truist Securities analyst Richard Newitter upgraded Globus Medical (NYSE: GMED) from Hold to Buy with a price target of $93.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
